
|Articles|November 1, 2001
Topical dapsone gel offers dual mode of action in phase III studies
Modality has antibacterial activity against P. acnes and an independent,potent anti-inflammatory effect
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756
5

















